generic times product news

CareNatal DHATablets

Marketed by:ETHEX Corp(St. Louis, Mo)

Compared to:StuartNatal Duet DHA(XanodynePharmaceuticals Inc)

Indication:January 15, 2007?ETHEX Corp introduced CareNatalDHA, the first and only multisource prescription prenatalvitamin with DHA (docosahexaenoic acid).CareNatal DHA is indicated for use in improving thenutritional status of women prior to conception,throughout pregnancy, and in the postnatal period forboth lactating and nonlactating mothers. Health careprofessionals can compare the active ingredients onthe label of CareNatal DHA with the active ingredientson the label of StuartNatal Duet DHA. The productcontains a multivitamin (with 15 vitamins and minerals,including 29 mg of iron) and a DHA soft gelatincapsule of 250 mg of purified omega-3 fatty acid.

Dosage Form:5 unit-dose cards of 6 prenatal multivitamin/multimineraltablets and 6 omega-3 fatty-acid soft gelatin capsules

For More Information:www.ethex.com

Ciclopirox TopicalSuspension USP, 0.77%

Marketed by:Perrigo Co (Allegan, Mich)

Compared to:Loprox Topical Suspension,0.77% (Medicis PharmaceuticalCorp)

Indication:December 19, 2006?The Perrigo Co announced thatit received FDA approval to manufacture and marketCiclopirox Topical Suspension USP, 0.77%. This lotion isan antifungal medication indicated for the topicaltreatment of common skin infections such as tineapedis (athlete's foot), tinea cruris (jock itch), and tineacorporis (ringworm) due to Trichophyton rubrum,T mentagrophytes, Epidermophyton floccosum, andMicrosporum canis.

Dosage Form:60-mL bottle

For More Information:www.perrigo.com

OndansetronHydrochlorideTablets, 4, 8, 16,and 24 mg

Marketed by:Dr. Reddy's Laboratories Ltd (Hyderabad, India)

Compared to:Zofran (GlaxoSmithKline)

Indication:December 27, 2006?Dr. Reddy's Laboratoriesannounced that the FDA granted final approval for itsabbreviated new drug application (ANDA) forOndansetron Hydrochloride Tablets, 4, 8, 16, and 24mg. Because the company was the first to file anANDA containing a paragraph IV certification for thisproduct, Dr. Reddy's has been awarded a period of180 days of marketing exclusivity. These tablets areindicated for the prevention of nausea and vomitingassociated with surgery, radiotherapy, and cancertreatment.

Dosage Form:Tablets: 4, 8, 16, and 24 mg

For More Information:www.drreddys.com

Sulfamethoxazole andTrimethoprim OralSuspension USP

Marketed by:Teva Pharmaceuticals(North Wales, Pa)

Compared to:Septra Suspension (MonarchPharmaceuticals Inc)

Indication:December 22, 2006?TevaPharmaceuticals announced the introductionand availability of Sulfamethoxazole andTrimethoprim Oral Suspension USP. To reduce thedevelopment of drug-resistant bacteria and maintainthe effectiveness of sulfamethoxazole and trimethoprimand other antibacterial drugs, this product shouldbe used only to treat or prevent infections that areproven or strongly suspected to be caused by susceptiblebacteria. It may be used for the treatment ofsuch infections as urinary tract infections, acute otitismedia, and acute exacerbations of chronic bronchitisin adults, among others, caused by susceptiblebacteria.

Dosage Form:473-mL bottle: 200 mg/40 mg/5-mL strength

For More Information:www.tevausa.com